Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,748 total articles
Interparfums, Inc. reported a 2% increase in consolidated net sales for Q1 2026 to $345 million, driven by solid performances in select brands and favorable foreign exchange rates. Organic sales declined by 2% when adjusted for the Middle East conflict. Key growth brands included Coach and Montblanc, while Lacoste and overall Jimmy Choo sales decli…
Immuneering announced it will present updated survival data from a Phase 2a clinical trial evaluating the combination of atebimetinib and modified gemcitabine/nab-paclitaxel (mGnP) in first-line pancreatic cancer patients. The expanded cohort includes 55 patients, highlighting the drug's mechanism designed to improve survival by durable tumor shrin…
American Coastal Insurance Corporation, a Florida-based insurance holding company specializing in insuring condominium and homeowner association properties, plans to release its Q1 2026 financial results on May 5, 2026. The company will hold a conference call immediately after, providing remarks and a Q&A session to discuss the quarter's performanc…
Sight Sciences, a US-based eyecare technology company specializing in minimally invasive glaucoma and dry eye treatment devices, will report its first quarter 2026 financial results on May 6, 2026. The company will hold a conference call to discuss these results. This update reiterates the company’s ongoing commitment to advancing interventional ey…
Beeline Holdings, a digital mortgage fintech company listed on NASDAQ under the ticker BLNE, announced it will hold a stakeholder update call on May 14, 2026, to review its Q1 2026 financial results and discuss ongoing initiatives. The call will be hosted by the CEO and CFO and is available via webcast and toll-free dial-in.
Oculis Holding AG has published its invitation to the 2026 Annual General Meeting scheduled for May 13, 2026, in Zug, Switzerland, including details for in-person attendance and webcast access. Additionally, the company will host a shareholder information session on May 11, focusing on meeting proposals and company updates. Oculis continues to adva…
AvePoint, a leader in AI data protection and governance, announced it will report its Q1 2026 financial results on May 7, 2026, followed by a conference call to discuss financial performance and business trends. The company provides unified data security and resilience solutions across multiple cloud platforms, serving over 28,000 customers globall…
Foghorn Therapeutics presented new preclinical data demonstrating the efficacy and safety of its innovative drug candidates targeting chromatin regulatory proteins involved in cancer. The lead compound, selective SMARCA2 inhibitor FHD-909, in combination with an anti-PD-1 antibody, showed complete and durable tumor regression and immune memory in m…
Monarch Casino & Resort, Inc. reported record financial results for Q1 2026, with net revenue increasing 8.9% to $136.6 million and net income rising 38.9% to $27.6 million compared to the prior year. Adjusted EBITDA grew 19% and margins improved significantly. The company increased market share at both its Atlantis and Monarch Black Hawk propertie…
Beta Bionics announced a 57% year-over-year increase in net sales for Q1 2026, driven by growth in both Durable Medical Equipment and Pharmacy Benefit Plan channels. The company improved its gross margin significantly and reduced its net loss compared to Q1 2025. Beta Bionics also raised its full-year 2026 revenue and gross margin guidance, reflect…
Olema Oncology announced it will present initial Phase 1 clinical data for its investigational drug OP-3136, a novel selective KAT6A/B inhibitor, at the 2026 ASCO Annual Meeting. The company will also provide updates on its ongoing Phase 3 OPERA-02 trial involving palazestrant plus ribociclib for advanced breast cancer. OP-3136 shows potent anti-pr…
Wave Life Sciences, a biotechnology company developing RNA-based medicines, has filed for shareholder and Singapore High Court approvals to redomicile its parent company from Singapore to the United States. The move aims to position the company advantageously for future growth and regulatory alignment, subject to customary approvals and closing con…
TrustCo Bank Corp NY reported a net income of $16.3 million for the first quarter of 2026, a 14.1% increase from the prior year. The bank's net interest income grew 10.7% to $44.7 million due to successful loan portfolio repricing and disciplined deposit pricing strategies, which led to a 20 basis point expansion in net interest margin to 2.84%. Lo…
Cytokinetics, a biopharmaceutical company specializing in cardiac muscle biology, announced its plan to release first quarter 2026 financial results on May 5, 2026, followed by a management conference call to discuss its financial performance and business updates. The company is advancing its pipeline of cardiac therapies, including the approved dr…
Belite Bio has initiated the rolling submission of a New Drug Application (NDA) to the FDA for tinlarebant, an oral therapy aimed at treating Stargardt disease type 1 (STGD1). The drug has received Breakthrough Therapy Designation and is backed by positive Phase 3 clinical data. The company plans to complete submission by Q2 2026 and is preparing f…
Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO), parent company of F&M Bank, announced the appointment of Shalini Singhal as Chief Information and Technology Officer. Singhal, previously the Chief Information Officer, will lead technology strategy focusing on innovation, digital transformation, and cybersecurity to support business growth and oper…
Fortinet Inc. has been honored as the 2026 Google Cloud Partner of the Year for Workload Security, recognizing its FortiCNAPP platform's innovative integration and protection of cloud workloads across hybrid and multi-cloud environments. The award emphasizes Fortinet's leadership in cloud security and its collaborative partnership with Google Cloud…
Sports Entertainment Gaming Global Corporation's subsidiary Quadrant has released a high-engagement YouTube video featuring Formula 1 drivers Carlos Sainz Jr. and Lando Norris, celebrating the 100th anniversary of karting. The campaign generated over four million views and significant social media impressions, reinforcing Quadrant's content strateg…
Independent Bank Corporation announced a quarterly cash dividend of $0.28 per share payable on May 14, 2026, to shareholders of record as of May 4, 2026. The Michigan-based community bank holds approximately $5.5 billion in assets and provides a full range of financial services throughout Michigan's Lower Peninsula.
SiriusPoint Ltd has received an upgrade from S&P Global Ratings on its core insurance operating subsidiaries to 'A' from 'A-', marking the company's third upgrade this year. The holding company rating was also raised to 'BBB+' from 'BBB' with a stable outlook. The upgrades are attributed to SiriusPoint's consistent underwriting performance, de-risk…
Royalty Pharma plc has announced the establishment of the Royalty Pharma Translational Prize, an annual $1 million award recognizing scientists who have successfully translated fundamental scientific discoveries into impactful new medicines. The prize aims to encourage translational research and will be awarded by an independent committee chaired b…
OpenTable, part of Booking Holdings, Inc., announced its annual Top 100 Brunch and Lunch Restaurants in Canada for 2026 and shared consumer trends for Mother’s Day dining, revealing that 65% of Canadians consider dining out an important part of their celebration. The data highlights evolving celebration styles including solo dining, larger family g…
United Fire Group, Inc. announced it will release its first quarter 2026 earnings results after market close on May 5, 2026, followed by an earnings call on May 6. The company invites analysts, investors, and stakeholders to participate via teleconference or webcast. The event will be archived for replay and a transcript will be available. United F…
Revolution Medicines announced that detailed results from its pivotal Phase 3 RASolute 302 clinical trial of daraxonrasib, an oral RAS(ON) multi-selective inhibitor, in previously treated metastatic pancreatic ductal adenocarcinoma patients, will be presented at the 2026 ASCO Annual Meeting. The topline data showed statistically significant and cli…
Northeast Bank announced it will release its fiscal 2026 third quarter earnings on April 27, 2026, followed by a conference call on April 28, 2026. The call will be hosted by senior executives and available via live webcast and phone. Northeast Bank operates as a national lender and community bank, focusing on commercial real estate loans and small…
